Personalized CAR-T Cell Therapy

Personalized CAR-T Cell Therapy

Researchers at the Harvard Wyss Institute and the Dana-Farber Cancer Institute have developed a new method to prepare chimeric antigen receptor-T cells (CAR-T cells) for leukemia patients that could result in more effective treatment. CAR-T cells start life as T cells that are isolated from cancer patients, are stimulated and primed to recognize and attack cancer cells, expanded in number, and then reintroduced to the cancer patient with the goal that the cells will destroy their cancer. However, the technique works better in certain patients, and the researchers behind this latest technique have realized that T-cells from cancer patients do […]…

Continue Reading
Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Dr. Ty Vachon, CEO & Co-Founder at Oatmeal HealthToday, cancer is the second leading cause of death in the United States. Sadly, cancer disparities exist, with racial/ethnic minority, low-income, and uninsured populations suffering the greatest burden. That’s why routine cancer screening is critical to addressing cancer disparities as they have the potential to greatly reduce both incidence and mortality rates. To address this, Federally qualified health centers (FQHCs) are funded by the Health Resources and Services Administration to provide preventive and primary healthcare services, including cancer screening, to the nation’s most vulnerable populations We recently sat down with Oatmeal Health’s Co-Founder and…

Continue Reading
RTLS Can Enhance the Patient Experience, Staff Safety, and Workflow Operations in 2023

RTLS Can Enhance the Patient Experience, Staff Safety, and Workflow Operations in 2023

Scott Hondros, MHA, SCPM, VP of Professional Services at CenTrakAlthough the healthcare industry has shown significant resilience, the byproduct of the pandemic has amplified staff stressors across all operational and clinical roles. In a study conducted in 2022, more than one-third (34%) of the participating registered nurses (RN) stated that it was likely they would leave bedside nursing by the end of the year. Almost half (44%) cited both burnout and high-stress environments as their main reasons to retire or pursue other careers. As staff shortages increase, so do workloads. Forty-three percent of the nurses that responded to Hospital IQ’s recent survey…

Continue Reading
Nanowire Assay Detects Brain Tumors from Urine

Nanowire Assay Detects Brain Tumors from Urine

Researchers at Nagoya University in Japan have developed a nanowire assay that can be used to capture and detect specific extracellular vesicles in a urine sample that indicate the presence of a brain tumor. These extracellular vesicles are naturally excreted in the urine but techniques to capture and analyze them have been complex, requiring different pieces of equipment, until now. This all-in-one assay uses a simple well plate that has been coated with zinc oxide nanowires that extracellular vesicles are attracted to because of their surface electrical charge. Then, the researchers can detect tumor-specific extracellular vesicles in each well using […]…

Continue Reading
Epic remains Best in KLAS for overall software suite for 13th year

Epic remains Best in KLAS for overall software suite for 13th year

In addition to winning overall, Epic was named top Overall Physician Practice Vendor based on provider feedback in this year’s Best in KLAS awards. The health IT giant also earned plaudits in 13 other categories, the research firm announced Wednesday.Of note, Impact Advisors and Nordic are tied as co-winners of the Overall IT Services category. 
Impact Advisors also took top placements in ERP Implementation Leadership, Financial Improvement Consulting and Security & Privacy Consulting Services categories while Nordic won for HIT Core Clinical Implementation Leadership.
The KLAS announcement noted that Nordic also scored above 90 in four separate services segments, which is detailed in 2023…

Continue Reading
New York approves AI-driven breast cancer diagnostic

New York approves AI-driven breast cancer diagnostic

With Clinical Laboratory Evaluation Program assay validation, the company’s Clinical Laboratory Improvement Amendments-certified lab can begin testing patient samples.WHY IT MATTERS
Along with New York State Department of Health clinical and analytical validation of this use of array morphology, the results of the PDxBr test were reproducible.
“Consistent with our mission of improving healthcare, PDxBr has shown to be an effective prognostic tool to further improve risk stratification over current histopathology methods,” said Wayne Brinster, CEO of PreciseDx, in an announcement.
The company says the AI technology has now proven its ability to enhance invasive breast cancer pathology interpretation with objective, quantifiable and accurate…

Continue Reading
HCA uses AI to decrease time from cancer diagnosis to first treatment by almost a week

HCA uses AI to decrease time from cancer diagnosis to first treatment by almost a week

HCA Healthcare has 14 hospitals covering a radius of more than 300 miles. The staff members knew they had a large catchment area. However, caseloads were based on registry data that was delayed, and not a true reflection of the provider organization’s oncology program as a whole.THE PROBLEM
“With multiple points of entry, we relied on manual searches through pathology, physician schedules and referrals to identify newly diagnosed cancer cases and patients,” said Kristina Rua, RN, an oncology nurse, oncology nurse navigator and president of the Florida Academy of Oncology Nurse and Patient Navigators, who previously was director of oncology navigation services in…

Continue Reading